MYLAN-EZETIMIBE ezetimibe 10 mg tablets blister pack
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
17-01-2021
अनुरोध भेजा।
सक्रिय संघटक:
ezetimibe, Quantity: 10 mg
थमां उपलब्ध:
Alphapharm Pty Ltd
फार्मास्यूटिकल फॉर्म:
Tablet
रचना:
Excipient Ingredients: magnesium stearate; microcrystalline cellulose; lactose monohydrate; sodium lauryl sulfate; hypromellose; croscarmellose sodium; crospovidone
प्रशासन का मार्ग:
Oral
पैकेज में यूनिट:
30, 10, 5
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
Primary Hypercholesterolaemia,Ezetimibe administered alone, or with an HMG-CoA reductase inhibitor (statin), is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia.,Homozygous Familial Hypercholesterolaemia (HoFH),Ezetimibe, administered with a statin, is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
उत्पाद समीक्षा:
Visual Identification: White to off white capsule shaped, bevelled edge tablet debossed with M on one side of the tablet and EE1 on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
प्राधिकरण का दर्जा:
Registered
प्राधिकरण की तारीख:
2021-01-11
